EYEFLOX 0.03% Eye Drops 5 ml

Frequently asked questions

• Onset of action

  Ophthalmic form: The amount of time required for this medicine to show its action is not clinically established. Oral form: The effect of this medicine can be observed within 1 to 2 hours of administration of the dose.

• Duration of Effect

  Ophthalmic form: The amount of time for which this medicine remains active in the body is not clinically established. Oral form: The amount of time for which this medicine remains active in the body is not clinically established.

• Safe with Alchohol?

  Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

• Is it habit forming?

  No habit-forming tendencies were reported.

• Usage in pregnancy?

  This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using/taking this medicine.

• Usage while breast-feeding?

  This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using/taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

• Allergy

  This medicine is not recommended for use in patients with a known allergy to EYEFLOX 0.03% Eye Drops 5 ml , any other NSAIDs, or any other inactive ingredients present along with it.

• Coronary Artery Bypass Surgery (CABG)

  This medicine is not recommended for use in patients planning to undergo a coronary artery bypass surgery or patients with a recent heart surgery due to the increased risk of severe adverse reactions.

• NSAID-induced asthma

  This medicine is not recommended for use in patients with a history of non-steroidal anti-inflammatory drug (NSAID) induced or aspirin-induced asthma due to the increased risk of a recurrent asthma attack.

• Severe heart failure

  This medicine is not recommended for use in patients with severe heart failure due to the increased risk of worsening of the patient's condition.

• Severe renal impairment

  This medicine is not recommended for use in patients with severe kidney impairment due to the increased risk of worsening of the patient's condition.

• Severe Hepatic impairment

  This medicine is not recommended for use in patients with severe liver impairment due to the increased risk of worsening of the patient's condition.

• Pregnancy

  This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using/taking this medicine.

• Breast-feeding

  This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using/taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

• Heart disease

  The oral form of this medicine should be used with caution in patients with heart diseases due to the increased risk of adverse effects on the heart, especially after prolonged use. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

• Kidney impairment

  The oral form of this medicine should be used with caution in patients with mild to moderate kidney impairment due to the increased risk of adverse effects. You may require a dose adjustment and more frequent monitoring of the kidney function tests is necessary while receiving this medicine. Replacement with a suitable alternative may be required based on the clinical condition.

• Liver impairment

  The oral form of this medicine should be used with caution in patients with mild to moderate liver impairment due to the increased risk of adverse effects. You may require a dose adjustment and more frequent monitoring of the liver function is necessary while receiving this medicine. Replacement with a suitable alternative may be required based on the clinical condition.

• Increased bleeding time

  This medicine should be used with caution in patients with a known history of bleeding disorders due to the increased risk of excessive bleeding. Report any unusual symptoms to the doctor immediately. Close monitoring of bleeding time, appropriate corrective measures, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

• Herpes simplex keratitis

  The ophthalmic form of this medicine should be used with caution in patients with herpes simplex keratitis due to the increased risk of worsening of the patient's condition. Close monitoring of the clinical condition, appropriate corrective measures, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

• Corneal reactions

  Prolonged use of an ophthalmic form of this medicine may result in keratitis, epithelial breakdown, corneal thinning, corneal erosion, corneal ulceration, or corneal perforation in some patients. Appropriate corrective measures or replacement with a suitable alternative may be required based on the clinical condition of the patient.

• Driving or operating machinery

  Use of this medicine may cause blurred vision or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

• Contact lens

  Your doctor may ask you to stop the usage of contact lenses for up to a few days prior to the surgery and for up to a few days to a few months post-surgery depending on the type of eye surgery performed. If you are able to use contact lenses post-surgery, they should be removed prior to the administration of the eye drops. You are advised to wait for at least 10 to 15 minutes post administration of the eye drops before re-inserting the lenses.

• Contamination

  Do not touch the tip of the dropper to any surface since this may lead to contamination by bacteria. Patients are advised to take all hygienic precautions to ensure that the medicine is not contaminated.

• Skin rash

  The oral form of this medicine may cause fatal skin allergies without any warnings in some patients. Signs and symptoms such as rashes, hives, fever, or other allergic symptoms should be reported to the doctor without any delay. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Oral form: Take this medicine exactly as prescribed by the doctor. Do not take in larger or smaller quantities than recommended. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor. Ophthalmic form: Use this medicine exactly as prescribed. Do not administer in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor. If this medicine is used during surgeries, it is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional.

• Usage does not depend on food timings
• To be taken as instructed by doctor
• Effect on sleep is not established

• medlineplus.gov - Flurbiprofen [Internet]. Available from: https://medlineplus.gov/druginfo/meds/a687005.html [cited 3/9/2020]. 2020